Motherisk News: Pre-emptive treatment found effective in the prevention of severe nausea and vomiting of pregnancy

MOTHERISK NEWS

October 14, 2004

Pre-emptive treatment found effective in the prevention of severe nausea and vomiting of pregnancy

Researchers in the Motherisk Program at The Hospital for Sick Children (Motherisk) have shown that treatment for nausea and vomiting of pregnancy (NVP), more commonly known as "morning sickness," before the appearance of symptoms can prevent severe NVP and hyperemesis gravidarum. This research is reported in the current issue of the Journal of Obstetric Gynaecology.

NVP affects 80% of pregnancies. Its severe form, hyperemesis gravidarum results in dehydration, electrolyte imbalance and hospitalization. In rare instances, hyperemesis can be fatal. The Motherisk study looked at 25 women who had severe NVP or hyperemesis in a previous pregnancy, and counseled them to take Diclectin, a safe and approved antiemetic, while planning their next pregnancy (before conception) or very early in the pregnancy before the appearance of NVP symptoms. The researchers then provided counseling throughout the pregnancy on how to modify the antiemetic dose based on NVP symptoms. The research objective was to evaluate the effectiveness of the pre-emptive approach to therapy.

The women in the study group were compared to a group of randomly selected women who also had severe NVP, but who did not call the Motherisk NVP Helpline for counseling before they conceived, and therefore could not be offered pre-emptive therapy.

"We found that the majority of the women in the study group experienced far less severe NVP symptoms during the index pregnancy, compared to their previous pregnancy. Symptoms among women in the comparison group remained severe in 80% of the cases," said Dr. Gideon Koren, the study's principal investigator, director of the Motherisk Program and a senior scientist in the Sick Kids Research Institute. "Motherisk hears from women around the world who had terrible NVP or had to be hospitalized for hyperemesis during pregnancy. Many tell us how scared they are about getting pregnant again, even though they would like to have another child. This study confirms that severe NVP can be prevented with pre-emptive treatment," said Dr. Koren.

The other member of the research team was Caroline Maltepe, an information specialist in NVP and bi-lingual (English-French) counselor on the Motherisk NVP Helpline (1-800-436-8477). Women who are pregnant or planning pregnancy can call toll-free from anywhere in North America to receive evidence-based information and counseling on how to deal with NVP and hyperemesis gravidarum.

For more information call the Motherisk NVP Helpline at 1-800-436-8477.

ABOUT MOTHERISK

Motherisk counselors talk to hundreds of women and their healthcare providers each day providing guidance, support and peace of mind. So if
you don't find the information you are looking for on this website, try calling one of our Helplines. Motherisk counselors are available Monday through Friday, from 9
a.m. to 5 p.m. EST.

OTHER MOTHERISK RESOURCES

The following corporations have provided financial support of $5,000 or more to Motherisk Programs and/or research since 2011: Beer Canada, Duchesnay, LCBO, Novartis and Shoppers Drug Mart. Funding from these organizations and their customers support Motherisk's research, helplines and other activities, but are not associated with the Motherisk Drug Testing Laboratory.

In addition, Dr. Gideon Koren, founding Director of Motherisk, acted as a consultant to Bayer, Novartis and Duchesnay during this time period.

* - "MOTHERISK - Treating the mother - Protecting the unborn" is an official mark of The Hospital for Sick Children. All rights reserved.

The information on this website is not intended as a substitute for the advice and care of your doctor or other health-care provider. Always
consult your doctor if you have any questions about exposures during pregnancy and before you take any medications.

The Hospital for Sick Children (SickKids) is a health-care, teaching and research centre
dedicated exclusively to
children;
affiliated with the University of Toronto. For general inquires please call: 416-813-1500.